Medicine and Dentistry
Targeted Therapy
100%
Breast Cancer
100%
Cancer Resistance
100%
Antibodies
100%
Therapeutic Procedure
75%
Uvomorulin
50%
Experimental Therapy
50%
Patient
50%
Drug
50%
Diseases
25%
Protein
25%
Oncology
25%
Protein Tyrosine Kinase
25%
Protein P53
25%
Epidermal Growth Factor Receptor
25%
Cancer Cell
25%
Tumor Progression
25%
Hyperactivation
25%
Growth Factor Receptor
25%
Progression Free Survival
25%
Akt/mTOR Signaling
25%
Host Resistance
25%
Gamma Urogastrone
25%
Biological Product
25%
Cells
25%
Hormone Receptor
25%
Therapeutics
25%
Monoclonal Antibody
25%
Mitogen-Activated Protein Kinase
25%
Receptor
25%
Marker
25%
Breast
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Resistance
100%
Breast Cancer
100%
Antibodies
100%
Uvomorulin
50%
Drug
50%
Malignant Neoplasm
25%
Host
25%
Biological Product
25%
Progression Free Survival
25%
Protein Tyrosine Kinase
25%
Protein P53
25%
Gamma Urogastrone
25%
Growth Factor Receptor
25%
Protein
25%
Tumor Growth
25%
Disease
25%
Hormone Receptor
25%
Epidermal Growth Factor Receptor
25%
Monoclonal Antibody
25%
Receptor
25%
Biochemistry, Genetics and Molecular Biology
Antibodies
100%
Cadherin
50%
Protein
25%
Cancer Cell
25%
Akt/mTOR Signaling
25%
Host Resistance
25%
Progression Free Survival
25%
Receptor Tyrosine Kinase
25%
Mitogen-Activated Protein Kinase
25%
Growth Factor Receptor
25%
Tumor Progression
25%
Hormone Receptor
25%
Monoclonal Antibody
25%
Epidermal Growth Factor Receptor
25%
P53
25%